MOMO-0201 – Belgium as a leading example in the management of drug shortages: A multi-angle approach
Dr Michael Storme, Mr Koen Straetmans 
Drug shortages are increasingly affecting patients, healthcare providers, and policy globally, impacting essential and common medicines like antibiotics. Belgium has implemented a multi-angle approach through a stakeholders’ working group under the National Competent Authority. This group includes pharmacists, industry representatives, and patient organisations, developing actions and legislative frameworks to manage shortages. They utilise a reporting system (farmastatus.be/pharmastatus.be) to categorise shortages by impact, facilitating effective management. As of February 2024, the majority of shortages were categorised as low impact, highlighting the efficacy of Belgium‘s collaborative approach in minimising disruptions to patient care. 

MOMO-0202 – Projects and initiatives that revolutionise hospital pharmaceutical care for patients and healthcare professionals
Mrs Despoina Makridaki 
This session will  communicate the European Association of Hospital Pharmacists (EAHP) main policy activities, educational projects and input to the new  European pharmaceutical legislation. The EAHP’s engagement on improving access to medicines  (e.g., tackling medicines shortages, combating antimicrobial resistance, crisis preparedness, hospital pharmacy workforce, the new European Council for Pharmacy, and the activities of EAHP Special Interest Groups) will also be presented.